Yale University: Cognitive Dysfunction trials

The registry lists 12 Cognitive Dysfunction studies with Yale University as lead sponsor. 2 are open to participants now and 6 have results posted.

Early Phase 1 1Phase 1 2Phase 2 4Phase 3 2No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Music for Pain and DementiaRecruitingNCT07602283Not applicable
• Cognitive-Behavioral Therapy for Irritability in Children With Autism Spectrum Disorder and Intellectual DisabilityEnrolling by invitationNCT02914951Not applicable
• Cognitive Remediation and Work Therapy in the Initial Phase of Substance Abuse TreatmentCompletedNCT01410110Phase 2Results posted
• Guanfacine Treatment for Prefrontal Cognitive Dysfunction in Elderly SubjectsCompletedNCT00935493Not applicableResults posted
• N-acetylcysteine and NMDA Antagonist InteractionsCompletedNCT00611897Phase 1/2Results posted
• Cannabidiol Treatment of Cognitive Dysfunction in SchizophreniaCompletedNCT00588731Phase 2Results posted
• Modafinil, Sleep, and Cognition in Cocaine DependenceCompletedNCT00582491Not applicableResults posted
• D-Serine Treatment of Negative Symptoms and Cognitive Deficits in SchizophreniaCompletedNCT00237809Phase 3Results posted
• Neurophysiological Benefits of Live Music for Early Alzheimer's Patients and Their CaregiversCompletedNCT06940687Not applicable
• Characterizing Clinical and Pharmacological Neuroimaging BiomarkersCompletedNCT03842800Early Phase 1
• GABA-glutamate Interactions and PsychosisCompletedNCT00611572Phase 1
• Galantamine for Cognitive Deficits in SchizophreniaCompletedNCT00463879Phase 2/3